Literature DB >> 9642263

Human ADAM 12 (meltrin alpha) is an active metalloprotease.

F Loechel1, B J Gilpin, E Engvall, R Albrechtsen, U M Wewer.   

Abstract

The ADAMs (a disintegrin and metalloprotease) are a family of multidomain proteins with structural homology to snake venom metalloproteases. We recently described the cloning and sequencing of human ADAM 12 (meltrin alpha). In this report we provide evidence that the metalloprotease domain of ADAM 12 is catalytically active. We used the trapping mechanism of alpha2-macroglobulin to assay for protease activity of wild-type and mutant ADAM 12 proteins produced in a COS cell transfection system. We found that ADAM 12 is synthesized as a zymogen, with the prodomain maintaining the metalloprotease in a latent form, probably by means of a cysteine switch. The zymogen could be activated chemically by alkylation with N-ethylmaleimide. Cleavage of the prodomain at a site for a furin-like endopeptidase resulted in an ADAM 12 protein with proteolytic activity. The protease activity was sensitive to inhibition by 1,10-phenanthroline and could be eliminated by mutation of the critical glutamate residue at the active site. The demonstration that the ADAM 12 metalloprotease domain is functional may have important implications for future studies that explore the role of ADAM 12 protein in development and disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642263     DOI: 10.1074/jbc.273.27.16993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.

Authors:  H Koike; S Tomioka; H Sorimachi; T C Saido; K Maruyama; A Okuyama; A Fujisawa-Sehara; S Ohno; K Suzuki; S Ishiura
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28.

Authors:  L Howard; R A Maciewicz; C P Blobel
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

3.  Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.

Authors:  Q Kang; Y Cao; A Zolkiewska
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1.

Authors:  Y Cao; Q Kang; A Zolkiewska
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

5.  Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.

Authors:  Haiqing Yi; Joanna Gruszczynska-Biegala; Denise Wood; Zhefeng Zhao; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2005-04-23       Impact factor: 5.157

6.  Selective modulation of integrin-mediated cell migration by distinct ADAM family members.

Authors:  Jing Huang; Lance C Bridges; Judith M White
Journal:  Mol Biol Cell       Date:  2005-08-03       Impact factor: 4.138

7.  ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis.

Authors:  Roopali Roy; Scott Rodig; Diane Bielenberg; David Zurakowski; Marsha A Moses
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

8.  The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis.

Authors:  N Rocks; C Estrella; G Paulissen; F Quesada-Calvo; C Gilles; M M Guéders; C Crahay; J-M Foidart; P Gosset; A Noel; D D Cataldo
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

9.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

10.  The regulation of TACE catalytic function by its prodomain.

Authors:  Xiaoou Li; Yuan Yan; Wei Huang; Yuzhen Yang; Hongwei Wang; Liwen Chang
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.